定量PSMA PET参数与病理ISUP分级的相关性:一项国际多中心分析
这项国际多中心研究纳入605例根治性前列腺切除术前接受PSMA PET分期的前列腺癌患者,评估SUVmax、PSMAvolume和PSMAtotal与术后病理ISUP分级组及升级/降级的相关性。多因素分析显示三个参数均与GG≥4相关,联合纳入可将预测GG≥4的AUC从68%提升至75%。作者提出可改善风险分层的临床相关阈值。
要点
- SUVmax、PSMAvolume和PSMAtotal均与术后病理ISUP GG≥4独立相关(均p<0.05)。
- 联合三个参数使预测GG≥4的AUC从68%升至75%(95%CI 71-80)。
- 活检GG1-3患者中PSMAvolume≥2与升级至GG≥4的OR 6.36(95%CI 1.47-27.6)相关。
核心结论
- 定量PSMA PET参数与手术病理ISUP分级组及升级相关,作者提出可用于日常临床实践改善前列腺癌风险分层的临床相关阈值。
研究设计与样本
- 国际多中心分析,纳入全球七家转诊中心接受根治性前列腺切除术(伴或不伴盆腔淋巴结清扫)且术前行PSMA PET分期的前列腺癌患者605例。
主要发现
- 605例患者中病理ISUP GG1、2、3、4、5分别占2%、37%、37%、10%和13%。
- 在校正PSA、基于DRE的临床T分期、医院和放射性配体后,SUVmax、PSMAvolume和PSMAtotal均与手术病理GG≥4相关(均p<0.05)。
- 加入三个参数后临床模型预测GG≥4的区分度从68%(95%CI 63-74)分别提升至SUVmax 74%(95%CI 69-79)、PSMAvolume 72%(95%CI 67-76)、PSMAtotal 74%(70-79),全部参数联合为75%(95%CI 71-80)(均p<0.05)。
- 决策树分析得出区分GG的阈值:SUVmax 0-6.5、6.5-15、15-28、>28,PSMAvol 0-2、2-9、9-20、>20,PSMAtotal 0-12、12-98、>98。
- PSMAvolume与GG升级显著相关(OR 1.03,95%CI 1.01-1.05);活检GG1-3患者中PSMAvolume≥2较<2与升级至ISUP GG≥4的更高比值比相关(OR 6.36,95%CI 1.47-27.6)。
关键数值与推荐
- SUVmax阈值分为0-6.5、6.5-15、15-28、>28。
- PSMAvolume阈值分为0-2、2-9、9-20、>20。
- PSMAtotal阈值分为0-12、12-98、>98。
临床怎么用
- 作者提出这些定量PSMA PET参数的临床相关阈值可用于日常临床实践改善前列腺癌风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess if PSMA PET quantitative parameters are associated with pathologic ISUP grade group (GG) and upgrading/downgrading. METHODS: PCa patients undergoing radical prostatectomy with or without pelvic lymph node dissection staged with preoperative PSMA PET at seven referral centres worldwide were evaluated. PSMA PET parameters which included SUVmax, PSMAvolume, and total PSMA accumulation (PSMAtotal) were collected. Multivariable logistic regression evaluated the association between PSMA PET quantified parameters and surgical ISUP GG. Decision-tree analysis was performed to identify discriminative thresholds for all three parameters related to the five ISUP GGs The ROC-derived AUC was used to determine whether the inclusion of PSMA quantified parameters improved the ability of multivariable models to predict ISUP GG ≥ 4. RESULTS: A total of 605 patients were included. Overall, 2%, 37%, 37%, 10% and 13% patients had pathologic ISUP GG1, 2, 3, 4, and 5, respectively. At multivariable analyses, all three parameters SUVmax, PSMAvolume and PSMAtotal were associated with GG ≥ 4 at surgical pathology after accounting for PSA and clinical T stage based on DRE, hospital and radioligand (all p < 0.05). Addition of all three parameters significantly improved the discrimination of clinical models in predicting GG ≥ 4 from 68% (95%CI 63 - 74) to 74% (95%CI 69 - 79) for SUVmax, 72% (95%CI 67 - 76) for PSMAvolume, 74% (70 - 79) for PSMAtotal and 75% (95%CI 71 - 80) when all parameters were included (all p < 0.05). Decision-tree analysis resulted in thresholds that discriminate between GG (SUVmax 0-6.5, 6.5-15, 15-28, > 28, PSMAvol 0-2, 2-9, 9-20 and > 20 and PSMAtotal 0-12, 12-98 and > 98). PSMAvolume was significantly associated with GG upgrading (OR 1.03 95%CI 1.01 - 1.05). In patients with biopsy GG1-3, PSMAvolume ≥ 2 was significantly associated with higher odds for upgrading to ISUP GG ≥ 4, compared to PSMAvolume < 2 (OR 6.36, 95%CI 1.47 - 27.6). CONCLUSION: Quantitative PSMA PET parameters are associated with surgical ISUP GG and upgrading. We propose clinically relevant thresholds of these parameters which can improve in PCa risk stratification in daily clinical practice.
引用
- Soeterik TFW, Heetman JG, Hermsen R, et al. The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis. Eur J Nucl Med Mol Imaging. 2024. PMID: 39088067. doi:10.1007/s00259-024-06847-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。